Pandemic & Infectious Disease — 2026-05-29
The Bundibugyo Ebola outbreak in the Democratic Republic of Congo and Uganda remains a public health emergency of international concern, with WHO experts this week recommending specific candidate vaccines and therapeutics for clinical trials. Meanwhile, FDA advisers voted to update COVID-19 vaccines for the 2026-2027 season to target the dominant XFG variant. Global surveillance capabilities and pandemic preparedness frameworks face scrutiny as experts warn that sustained financing is critical to prevent recurrence of outbreak patterns.















